Interpace Biosciences®, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Accrued Expenses and Long-term Liabilities (Tables)

Note 7 - Accrued Expenses and Long-term Liabilities (Tables)

3 Months Ended

Mar. 31, 2016

Notes Tables

Schedule of Accrued Liabilities [Table Text Block]

		March 31, 2016				December 31, 2015
Facilities realignment accrual		$	-			$	43
Self insurance accruals			66				137
Indemnification liability			875				875
Contingent consideration			659				659
Rent payable			104				127
DOJ settlement			750				250
Accrued professional fees			1,084				775
Taxes payable			622				591
Unclaimed property			544				546
All others			1,951				1,958
		$	6,655			$	5,961

Schedule of Other Assets and Other Liabilities [Table Text Block]

		March 31, 2016				December 31, 2015
Rent payable		$	27			$	52
Uncertain tax positions			3,468				3,425
DOJ settlement (indemnified by RedPath)			1,000				2,500
Other			201				201
		$	4,696			$	6,178